{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:57:28Z","timestamp":1769212648881,"version":"3.49.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8406-16","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T22:15:15Z","timestamp":1505427315000},"page":"2711-2717","source":"Crossref","is-referenced-by-count":14,"title":["The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD)"],"prefix":"10.2169","volume":"56","author":[{"given":"Masahiro","family":"Ohgiya","sequence":"first","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhisa","family":"Tamura","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Akagawa","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Global initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary d: revised 2011."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 532-555, 2007.","DOI":"10.1164\/rccm.200703-456SO"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification. Am J Respir Crit Care Med 186: 975-981, 2012.","DOI":"10.1164\/rccm.201207-1299OC"},{"key":"4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15412550903499506","volume":"7","author":"P Lange","year":"2011","unstructured":"4. Lange P, Mogelvang R, Marott JL, Vestbo J, Jensen JS. Cardiovascular morbidity in COPD: a study of general population. COPD 7: 5-10, 2011.","journal-title":"COPD Journal of Chronic Obstructive Pulmonary Disease","ISSN":"https:\/\/id.crossref.org\/issn\/1541-2555","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brekke PH, Omland T, Smith P, S\u00f8yseth V. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 102: 1243-1247, 2008.","DOI":"10.1016\/j.rmed.2008.04.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 364: 897-906, 2011.","DOI":"10.1056\/NEJMoa1007285"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Doherty MJ, Peterson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 52: 998-1002, 1997.","DOI":"10.1136\/thx.52.11.998"},{"key":"8","unstructured":"8. Japanese Guidelines for COPD Diagnosis and Management. 4th ed. Nagai A, Kurosawa H, Nishimura M, et al. The Japanese Respiratory Society, Tokyo, 2014: 25."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined plumonary fibrosis and emphysema in ideopathic plumonary fibrosis. Chest 144: 234-240, 2013.","DOI":"10.1378\/chest.12-2403"},{"key":"10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.171.1.2928513","volume":"171","author":"JR Mathieson","year":"1989","unstructured":"10. Mathieson JR, Mayo JR, Staples CA, M\u00fcller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 171: 111-116, 1989.","journal-title":"Radiology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol 33: 379-387, 1982.","DOI":"10.1016\/S0009-9260(82)80301-2"},{"key":"12","unstructured":"12. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm incre, emts versus limited three-level thin-section CT dor idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentqenol 169: 977-983, 1997."},{"key":"13","unstructured":"13. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis andemphysema: the value of high resolution computed tomography in assessment. Respiratory Med 84: 365-369, 1990."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kitaguchi Y, Fujimoto K, Hanaoka M, Honda T, Hotta J, Hirayama J. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction. Int J Chron Obstruct Pulmon Dis 9: 805-811, 2014.","DOI":"10.2147\/COPD.S65621"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cottin V. The impact of emphysema in pulmonary fibrosis. Eur Respir Rev 22: 128, 153-157, 2013.","DOI":"10.1183\/09059180.00000813"},{"key":"16","unstructured":"16. Cottin V, Nuens H, Brillet PY, et al; Grouped'Etude. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26: 586-593, 2005."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gruffydd-Jones K. GOLD guidelines 2011: what are the implications for primary care? Prim Care Respir J 21: 437-441, 2012.","DOI":"10.4104\/pcrj.2012.00058"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Seung HC, Lee HY, Lee KS, et al. The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). PLoS ONE 9: e107476, 2014.","DOI":"10.1371\/journal.pone.0107476"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schwartz DA, Fossen DSV, Davis DS, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149: 444-449, 1994.","DOI":"10.1164\/ajrccm.149.2.8306043"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Brett L, Harold RC, Talmadge EKJ, et al. Clinical course and prediction of survival in ideopathic pulmonary fibrosis. Am J Respir Crit Care Med 183: 431-440, 2011.","DOI":"10.1164\/rccm.201006-0894CI"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Athol UW, Sujal RD, Michael BR, et al. Idiopathic pulmonary fibrosis. A composite physiologic index derived from disease extent observe by computed tomography. Am J Respir Crit Care Med 167: 962-969, 2003.","DOI":"10.1164\/rccm.2111053"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/20\/56_8406-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T14:00:18Z","timestamp":1570111218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/20\/56_8406-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":21,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8406-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}